2010
DOI: 10.4236/ns.2010.21006
|View full text |Cite
|
Sign up to set email alerts
|

Review on nano-drugs

Abstract: Nano materials is a new type of drug carriers with very promising application. In recent years, great progress was achieved in making drugs own the characteristics of targeted and controlled release via nanotechnologies. This paper addressed the capability of nano drugs on targeting to cells, penetrating through epicyte, controlled release and the security issues resulting from its using. We gave the prospect of nano drugs in biology and medicine applying.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
17
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(17 citation statements)
references
References 35 publications
0
17
0
Order By: Relevance
“…However, at present, the basic theory of nanotechnology applied in medicine and the preparation of nano-drugs are still incomplete, especially the safety of nano-drugs has many problems remain to be explored in depth. Therefore, the research in the field of nanotechnology applied in pharmaceutical industry has a great deal of work needs to be done, but the superior capability that nano-drugs owns indicates a very wide range of applications in the clinical disease treatment [85]. Because Nano-drug carriers have high targeting, favorable sustained, controlled release capability and superior cell penetration ability, it can improve efficacy of drugs and reduce side effects.…”
Section: Discussionmentioning
confidence: 97%
“…However, at present, the basic theory of nanotechnology applied in medicine and the preparation of nano-drugs are still incomplete, especially the safety of nano-drugs has many problems remain to be explored in depth. Therefore, the research in the field of nanotechnology applied in pharmaceutical industry has a great deal of work needs to be done, but the superior capability that nano-drugs owns indicates a very wide range of applications in the clinical disease treatment [85]. Because Nano-drug carriers have high targeting, favorable sustained, controlled release capability and superior cell penetration ability, it can improve efficacy of drugs and reduce side effects.…”
Section: Discussionmentioning
confidence: 97%
“…An example is the recently FDA-approved "solvent-free formulation of paclitaxel for the treatment of metastatic breast cancer that utilises 130-nanometer albumin-bound (nab™) technology (Abraxane ® ; nab-paclitaxel) to circumvent the requirement for solvents" [19]. An interesting approach to underscore the various requirements for a nanoparticulated drug (or "nanodrug") strategy is presented by Y. Liu [20]. The author distinguishes between active and passively targeted nanodrugs, whereby the passive targeting to tissues or organs is due to the enhanced permeability of barriers and thus offers nanoparticles and nanodrugs a more accessible route to reach the targeted area.…”
Section: Nanoformulations As "Re-inventions"mentioning
confidence: 98%
“…The basic theory of nano-technology applied in medicine and the preparation of nano-drugs are still incomplete, especially the safety of nano-medicines has many problems remain to be explored in depth. Therefore, the research in the field of nano-technology applied in medicine has a great deal of work needs to be done, but the superior capability that nano-drugs owns indicates a very wide range of applications in the clinical disease treatment [53].…”
Section: Solid Lipid Nanoparticles In Pulmonary Deliverymentioning
confidence: 99%